Skip to Content

New Drug Approvals Archive - December 2007

See also: New Indications and Dosage Forms for December 2007

December 2007

Kuvan (sapropterin dihydrochloride) Tablets

Date of Approval: December 13, 2007
Company: BioMarin Pharmaceutical Inc.
Treatment for: Phenylketonuria

Kuvan (sapropterin dihydrochloride) is the synthetic form of 6R-BH4 (tetrahydrobiopterin), a naturally occurring enzyme cofactor that works in conjunction with phenylalanine hydroxylase to metabolize phenylalanine (Phe). Kuvan is indicated for the treatment of phenylketonuria, an inherited metabolic disease caused by a deficiency of the enzyme phenylalanine hydroxylase.

Bystolic (nebivolol)

Date of Approval: December 17, 2007
Company: Allergan, Inc.
Treatment for: Hypertension

Bystolic (nebivolol) is a once daily beta blocker approved for the treatment of hypertension.

New Drug Approvals Archive

More News Resources

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.